Trial Profile
Safety and efficacy of peptide 277 in type 1 diabetes mellitus patients with remaining insulin production.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Peptide p277 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.